P2‐076: A NOVEL ALTERNATIVE MODEL TO MMRM AS THE PRIMARY MODEL FOR SPORADIC AD CLINICAL TRIALS: THE PROPORTIONAL MMRM
Guoqiao Wang(Washington University in St. Louis), Randall J. Bateman(Washington University in St. Louis), Eric McDade(University of Pittsburgh), Yan Li(Anhui University of Technology), Andrew J. Aschenbrenner(Washington University in St. Louis), Scott Berry(Queen's University), Chengjie Xiong(Guangzhou Institutes of Biomedicine and Health), Jason Hassenstab(Washington University in St. Louis)
Cited by 2
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Alzheimer's disease
|Nature Reviews Disease Primers|2015|1.8k